Evgen Pharma Plc
Evgen Pharma is an AIM listed clinical stage drug development company developing medicines for the treatment of multiple diseases focusing on Oncology.
Our lead programme has completed a study in patients with oestrogen-positive (ER+) metastatic breast cancer and will be entering a Ph2 study in Glioma patients (Glioblastoma multiforme) in H2 2022.
We are open to partnering discussions as well as in-licensing/acquisition opportunities in cancer therapeutics and supportive care.
Dr Helen Kuhlman
Chief Business Officer
Dr Huw Jones
Chief Executive Officer
